Case Study: Multinational Biopharmaceutical Company reduces clinical data integration time from 6 weeks to 1 day with Tamr Inc.

Tamr Accelerates Preparation Of Clinical Data From 6 Weeks To 1 Day

Biopharma Company needed to unlock thousands of legacy clinical-trial and biomarker datasets to support translational research and drug development, but traditional ETL and statistical-programming approaches were too slow and inconsistent. The company engaged Tamr Inc. to tackle massive volume and variety—no schema alignment across studies, changing internal standards, and a six-week turnaround to integrate a new study—so scientists could access analytics-ready data across new and historical trials.

Tamr Inc. implemented its human-guided machine learning solution to automatically ingest SAS binary files, map legacy studies to a master schema with ML-guided matching and expert validation, provide point-and-click transformations, and generate documentation before loading aligned data into the existing pipeline. The result: integration time for a new clinical-study dataset fell from about six weeks to one day, enabling Biopharma Company’s translational scientists to analyze far more data faster and realize greater ROI from their clinical data.

Biopharma Company